BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35430511)

  • 1. Characterization of Moyamoya and Middle Cerebral Artery Diseases by Carotid Canal Diameter and RNF213 p.R4810K Genotype.
    Oichi Y; Mineharu Y; Agawa Y; Morimoto T; Funaki T; Hitomi T; Kobayashi H; Todo K; Tani S; Imamura H; Yoshida K; Kataoka H; Koizumi A; Sakai N; Miyamoto S
    J Stroke Cerebrovasc Dis; 2022 Jun; 31(6):106481. PubMed ID: 35430511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.
    Cao Y; Kobayashi H; Morimoto T; Kabata R; Harada KH; Koizumi A
    Environ Health Prev Med; 2016 Sep; 21(5):387-390. PubMed ID: 27365075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of
    Xue Y; Zeng C; Ge P; Liu C; Li J; Zhang Y; Zhang D; Zhang Q; Zhao J
    Stroke; 2022 Sep; 53(9):2906-2916. PubMed ID: 35543128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.
    Zhang T; Guo C; Liao X; Xia J; Wang X; Deng J; Yan J
    Environ Health Prev Med; 2017 Apr; 22(1):41. PubMed ID: 29165136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810K Variant.
    Zhang Q; Ge P; Ma Y; Zhang D; Wang R; Zhang Y; Wang S; Cao Y; Zhao M; Zhao J
    J Child Neurol; 2019 Nov; 34(13):793-800. PubMed ID: 31290353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
    Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
    J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.
    Morimoto T; Mineharu Y; Kobayashi H; Harada KH; Funaki T; Takagi Y; Sakai N; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2632-2636. PubMed ID: 27476341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
    Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
    Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
    Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
    PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
    Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose: The SUPRA Japan study: PCA involvement in unilateral moyamoya.
    Mineharu Y; Takagi Y; Koizumi A; Morimoto T; Funaki T; Hishikawa T; Araki Y; Hasegawa H; Takahashi JC; Kuroda S; Houkin K; Miyamoto S;
    J Stroke Cerebrovasc Dis; 2024 Feb; 33(2):107513. PubMed ID: 38141320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease: possible involvement of intrinsic vascular vulnerability.
    Uchino H; Ito M; Tokairin K; Tatezawa R; Sugiyama T; Kazumata K; Fujimura M
    Neurosurg Rev; 2023 May; 46(1):119. PubMed ID: 37166684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
    Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
    World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.
    Kobayashi H; Matsuda Y; Hitomi T; Okuda H; Shioi H; Matsuda T; Imai H; Sone M; Taura D; Harada KH; Habu T; Takagi Y; Miyamoto S; Koizumi A
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26126547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.
    Morimoto T; Mineharu Y; Ono K; Nakatochi M; Ichihara S; Kabata R; Takagi Y; Cao Y; Zhao L; Kobayashi H; Harada KH; Takenaka K; Funaki T; Yokota M; Matsubara T; Yamamoto K; Izawa H; Kimura T; Miyamoto S; Koizumi A
    PLoS One; 2017; 12(4):e0175649. PubMed ID: 28414759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive role of heterozygous p.R4810K of
    Wang Y; Zhang Z; Wei L; Zhang Q; Zou Z; Yang L; Li D; Shang M; Han C; Mambiya M; Bao X; Li Q; Hao F; Zhang K; Wang H; Liu S; Liu M; Zeng F; Nie F; Wang K; Liu W; Duan L
    Neurology; 2020 Feb; 94(7):e678-e686. PubMed ID: 31949090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.